Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_assertion type Assertion NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_head.
- NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_assertion description "[Taken together, our findings suggest that EGR4 likely regulates the bone metastasis and proliferation of SCLC cells via transcriptional regulation of several target genes, and may therefore be a promising target for the development of anticancer drugs for SCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_provenance.
- NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_assertion evidence source_evidence_literature NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_provenance.
- NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_assertion SIO_000772 25411851 NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_provenance.
- NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_assertion wasDerivedFrom befree-2016 NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_provenance.
- NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_assertion wasGeneratedBy ECO_0000203 NP1238830.RAxjaZPewg-KeNd3LomlkXEtLSZTU5e7QAC5X0e1aqeMY130_provenance.